4 European Projects Found
Searched on 125080 European Projects
FINISHED
Hub of Application Laboratories for Equipment Assessment in Laser Based Manufacturing (APPOLO)
Start date: Sep 1, 2013, End date: Aug 31, 2017,
During more than 50 years of the laser existence, they have been proved as the unique tool for diverse material processing application. New application ideas, coming from universities and research institutions, are usually implemented by spin-off companies with limited resources for market penetration. Research laboratories are using universal laser tools, while effective and low-cost production r ...
Read Project
36
Partners Participants
FINISHED
High throughput integrated technologies for multimaterial functional Micro Components (HINMICO)
Start date: Oct 1, 2013, End date: Sep 30, 2016,
Volume production at industrial scale of miniaturised multi-material 3D (polymer-polymer, metal-polymer, metal-metal, polymer-ceramics,...) still face important challenges to be affordable by SMEs. Challenges not only in terms of precision manufacturing (precision engineering
Read Project
16
Partners Participants
FINISHED
Advanced manufacturing processes for Low Cost Greener Li-Ion batteries (GREENLION)
Start date: Nov 1, 2011, End date: Oct 31, 2015,
GREENLION is a Large Scale Collaborative Project with the FP7 (topic GC.NMP.2011-1) leading to the manufacturing of greener and cheaper Li-Ion batteries for electric vehicle applications via the use of water soluble, fluorine-free, high thermally stable binders, which would eliminate the use of VOCs and reduce the cell assembly cost.GREENLION has 6 key objectives: (i) development of new act ...
Read Project
19
Partners Participants
FINISHED
Bringing Regenerative Medicine into the market: Allogeneic eASCs Phase IB/IIA clinical trial for treating Rheumatoid Arthritis (REGENER-AR)
Start date: Jan 1, 2012, End date: Dec 31, 2014,
Treating Rheumatoid Arthritis (RA) is a crucial challenge for the health systems. RA is the most common inflammatory arthritis, affecting 0.5% to 1% of the general population worldwide with little variation of the prevalence among countries.The current pharmacological management of RA involves early intervention with synthetic disease modifying anti-rheumatic drugs (DMARDs) either singly or in com ...
Read Project
